InvestorsHub Logo
Followers 2
Posts 436
Boards Moderated 0
Alias Born 01/14/2014

Re: None

Saturday, 05/26/2018 5:04:39 PM

Saturday, May 26, 2018 5:04:39 PM

Post# of 807
I think this is the start of the push for 1st line treatment. Kymriah has the advantage of freezing and out patient use. CRs out to 4yrs now in dlbcl

CAR T-Cell Therapy in DLBCL: Centers of Excellence
Panelists: Stephen J. Schuster, MD, University of Pennsylvania
Published: Friday, May 25, 2018